Completed PHASE1 INTERVENTIONAL 6-arm NCT03551769

Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

A Phase I, Open-label, Fixed-order, Single-dose, 2-Part, Crossover Study to Evaluate the Pharmacokinetics of a Formulation of Tricaprilin (AC-SD-01) Including the Effect of Food on Ketone Body Production in Caucasians and Asians

Sponsor: Cerecin

Conditions Alzheimer Disease

Interventions high-fat meal overnight fast standard meal tricaprilin

Updated 7 times since 2018 Last updated: May 27, 2019 Started: Aug 5, 2018 Primary completion: Aug 16, 2018 Completion: Aug 27, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Alzheimer Disease and is currently completed. Cerecin leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2019 — Jan 2021 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed
Nov 2018 — Jun 2019 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Sep 2018 — Nov 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Jul 2018 — Sep 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cerecin

Data source: Cerecin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia